Question 1

How many shares of PTGX does MARSHALL WACE, LLP own?

Accepted Answer

As of 2026-Q2, MARSHALL WACE, LLP holds 109,017 shares of PTGX (PROTAGONIST THERAPEUTICS INC).

Question 2

What is MARSHALL WACE, LLP's PTGX position worth?

Accepted Answer

As of 2026-Q2, MARSHALL WACE, LLP's PTGX position is worth $13.4M.

Question 3

Is MARSHALL WACE, LLP buying or selling PTGX?

Accepted Answer

In 2026-Q2, MARSHALL WACE, LLP decreased their PTGX position (-82.6% change in shares).

Question 4

When did MARSHALL WACE, LLP first buy PTGX?

Accepted Answer

Based on available 13F filings, MARSHALL WACE, LLP first reported a position in PTGX in 2024-Q3. They have held the position across 21 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	109,017	-82.6%	$13.4M	0.0%	$122.58	0
2026-Q1	Decreased	628,075	-38.7%	$66.2M	0.1%	$91.30	0
2025-Q4	Decreased	1M	-5.6%	$89.5M	0.1%	$87.26	0
2025-Q3	New	1.1M	—	$72.1M	0.1%	$65.14	41
2025-Q1	Exited	0	-100.0%	$0	0.0%	$48.88	0
2024-Q4	Decreased	19,716	-93.8%	$761,038	0.0%	$38.51	0
2024-Q3	Decreased	315,373	-44.9%	$14.2M	0.0%	$44.56	0